Robbins Farley’s Medtronic MDT Stock Holding History

Robbins Farley’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10	Closed	-$901	–	160
2024 Q3	$901	Buy	+10	New	+$841	﹤0.01%	132
2023 Q4	–	Sell	-36	Closed	-$2.82K	–	187
2023 Q3	$2.82K	Buy	+36	New	+$3.01K	﹤0.01%	134
2023 Q2	–	Sell	-36	Closed	-$2.9K	–	185
2023 Q1	$2.9K	Buy	+36	New	+$2.93K	﹤0.01%	151
2022 Q1	–	Sell	-122	Closed	-$13K	–	161
2021 Q4	$13K	Sell	122 -25	-17%	-$2.9K	0.01%	87
2021 Q3	$18K	Buy	+147	New	+$19K	0.01%	90

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Robbins Farley's MDT Position: Q4 2024 in Review

Robbins Farley sold out of Medtronic (MDT) in Q4 2024, closing a stake of 10 shares — an estimated $901 sold.

Robbins Farley first reported a position in MDT in Q3 2021 and held it in 5 quarters. The position peaked at $18K in Q3 2021. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

Robbins Farley reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
Robbins Farley sold 10 Medtronic shares in Q4 2024, an estimated $901.
Robbins Farley first reported a position in Medtronic in Q3 2021 and held it in 5 quarters.
Robbins Farley's Medtronic position peaked at $18K in Q3 2021.
2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Robbins Farley's 13F filing for Q4 2024, filed 27 Jan 2025.